The person shown in the image is not an actual patient
What is Mounjaro?
Mounjaro is a once weekly medicine for adults with Type 2 Diabetes and/or Chronic Weight Management. It contains an active ingredient called tirzepatide.
Mounjaro is used in conjunction with a reduced-calorie diet and increased physical exercise.1
How Mounjaro works
Mounjaro is not an insulin and works differently from other Type 2 Diabetes medicines.
Mounjaro can help:1,2*
The body release insulin when blood sugar is high
The body remove excess sugar from the blood
The liver from making and releasing too much sugar
Reduce how much food is eaten
Slow down how quickly food leaves the stomach
The body respond to the insulin it makes
*Individual patient results may vary.
Mounjaro can help:1,2*
Reduce and control body weight
Reduce appetite and how much food is eaten
Lower body fat
Slow down how quickly food leaves the stomach
*Individual patient results may vary.
REPORTING SIDE EFFECTS AND PRODUCT COMPLAINTS
Please review the Consumer Medicine Information (CMI) leaflet for your multi-use KwikPen. You can access the CMI online at www.lilly.com.au/en/products.
Side effects and product complaints should be reported. If you are worried about a side effect while taking a Lilly medicine, please contact your doctor. To report a side effect or a product complaint about a Lilly medicine, please call Lilly on: 1800 454 559. This information is brought to you by Lilly, the manufacturer of this medicine.
This medicine is subject to additional monitoring in Australia due to approval of an extension of indications. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
References
- MOUNJARO® Approved Product Information.
- MOUNJARO® Consumer Medicine Information.